课题基金 / 基金详情

Exploring preclinical amyloid pathology with optical microscopy

Exploring preclinical amyloid pathology with optical microscopy
用光学显微镜探索临床前淀粉样蛋白病理学
批准号:
10193586
负责人:
Mohammad Abbas Yaseen
金额:
$32.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-15 至 2022-08-31

项目摘要

项目成果

Mohammad Abbas Yaseen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT This project will investigate early pathophysiological hallmarks of Alzheimer's disease (AD) using newly- developed microscopy tools. Alzheimer's disease (AD) is a devastating, irreversible neurodegenerative disorder that currently has no effective treatment. Long before the first clinically-observable cognitive and behavioral symptoms of Alzheimer's disease (AD) arise, a “preclinical” incubation phase transpires, lasting up to ~2 decades and involving a myriad of changes at the cellular and vascular level. More detailed knowledge of these intricate, multifaceted preclinical alterations and their contributions to subsequent cognitive deterioration is essential to fill critical gaps in our understanding of AD's pathogenesis and to comprehensively assess the therapeutic potential of candidate treatments. Exploring the neurovascular and metabolic alterations that occur during the preclinical phase of AD could hold the key to understanding how to detect and counteract AD- related neurodegeneration. We have developed an array of innovative optical microscopy tools to noninvasively characterize multiple facets of cerebral blood flow and energy metabolism in living animal brains. These advanced techniques are ideally suited to characterize the convoluted progression of multiple pathophysiological features of preclinical AD. Specifically, these investigations will explore on a microscopic scale how accumulation of amyloid β and neuroinflammation, notable AD pathophysiological hallmarks, affect the neurovascular unit, cerebral oxygenation, energy metabolism, and cerebral blood flow. The results will help us understand in greater detail the multifactorial structural and functional changes that happen in the brain and collectively give rise to clinically-observable cognitive deficiencies. This project will yield insight into the mechanisms underlying AD pathogenesis with unprecedented detail, and it will facilitate the development of new therapeutic techniques widely applicable to the growing population of at-risk aging citizens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
  • 批准号:
    10443759
  • 项目类别:
  • 资助金额:
    $52.24万
  • 财政年份:
    2018
  • 负责人:
    Mohammad Abbas Yaseen
  • 依托单位:
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
  • 批准号:
    10227257
  • 项目类别:
  • 资助金额:
    $52.89万
  • 财政年份:
    2018
  • 负责人:
    Mohammad Abbas Yaseen
  • 依托单位:
In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy
  • 批准号:
    9150491
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2015
  • 负责人:
    Mohammad Abbas Yaseen
  • 依托单位:
In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy
  • 批准号:
    8510007
  • 项目类别:
  • 资助金额:
    $13.72万
  • 财政年份:
    2013
  • 负责人:
    Mohammad Abbas Yaseen
  • 依托单位:
国内基金
海外基金
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
  • 批准号:
    82372014
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    魏伟军
  • 依托单位: